Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.76% |
| 2 | Financials | 7.62% |
| 3 | Healthcare | 7.1% |
| 4 | Industrials | 5.08% |
| 5 | Consumer Discretionary | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4801
Zoom
ZM
$31.1B
| $562K | ﹤0.01% |
5,207
-698,284
| -99% | -$73.6M |
|
4802
Merchants Bancorp
MBIN
$2.5B
| $561K | ﹤0.01% |
24,748
+15,236
| +160% | +$372K |
|
|
PFC
4803
DELISTED
Premier Financial Corp. Common Stock
PFC
| $561K | ﹤0.01% |
22,131
-67,534
| -75% | -$1.82M |
|
|
RPTX
4804
CALL
DELISTED
Repare Therapeutics
RPTX
| $560K | ﹤0.01% |
+40,000
| New | +$471K |
|
4805
Byline Bancorp
BY
$1.76B
| $559K | ﹤0.01% |
23,481
-34,493
| -59% | -$834K |
|
4806
Hubbell
HUBB
$27.5B
| $559K | ﹤0.01% |
3,132
-282,531
| -99% | -$53.2M |
|
4807
CALL
Heron Therapeutics
HRTX
$61.5M
| $558K | ﹤0.01% |
+200,000
| New | +$803K |
|
4808
Universal Corp
UVV
$1.15B
| $557K | ﹤0.01% |
9,205
-12,992
| -59% | -$775K |
|
4809
CuriosityStream
CURI
$166M
| $556K | ﹤0.01% |
+328,971
| New | +$664K |
|
|
COOLU
4810
DELISTED
Corner Growth Acquisition Corp. Unit
COOLU
| $556K | ﹤0.01% |
56,285
| – | – |
|
|
ASCBU
4811
DELISTED
A SPAC II Acquisition Corp. Unit
ASCBU
| $555K | ﹤0.01% |
+55,500
| New | +$553K |
|
4812
Scholastic
SCHL
$780M
| $553K | ﹤0.01% |
15,374
+7,343
| +91% | +$271K |
|
4813
Ero Copper
ERO
$3.79B
| $552K | ﹤0.01% |
65,406
-97,206
| -60% | -$1.21M |
|
|
TRON
4814
DELISTED
Corner Growth Acquisition Corp. 2 Class A Ordinary Share
TRON
| $550K | ﹤0.01% |
54,687
-164,061
| -75% | -$1.64M |
|
4815
Charles River Laboratories
CRL
$13.5B
| $549K | ﹤0.01% |
2,568
-229,111
| -99% | -$56M |
|
4816
PDS Biotechnology
PDSB
$14.4M
| $549K | ﹤0.01% |
+150,497
| New | +$715K |
|
4817
CALL
AdaptHealth
AHCO
$754M
| $548K | ﹤0.01% |
+30,400
| New | +$494K |
|
4818
Dare Bioscience
DARE
$21.6M
| $547K | ﹤0.01% |
37,091
+15,758
| +74% | +$237K |
|
4819
Electromed
ELMD
$351M
| $547K | ﹤0.01% |
56,736
-5,210
| -8% | -$61.6K |
|
4820
Caleres
CAL
$475M
| $546K | ﹤0.01% |
20,804
-391,885
| -95% | -$9.7M |
|
4821
Claros Mortgage Trust
CMTG
$261M
| $546K | ﹤0.01% |
32,570
-457,742
| -93% | -$8.64M |
|
4822
PUT
Sutro Biopharma
STRO
$415M
| $545K | ﹤0.01% |
+10,460
| New | +$584K |
|
|
TDCX
4823
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
| $545K | ﹤0.01% |
58,948
-173,640
| -75% | -$2M |
|
|
IVAC
4824
DELISTED
Intevac Inc
IVAC
| $544K | ﹤0.01% |
112,464
+3,902
| +4% | +$19.9K |
|
4825
CALL
Intellia Therapeutics
NTLA
$1.68B
| $543K | ﹤0.01% |
+10,500
| New | +$533K |
|
Similar funds
Millennium Management's Q2 2022 Portfolio in Review
As of Q2 2022, Millennium Management held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Millennium Management deployed $7.94B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Millennium Management's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Millennium Management added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Millennium Management's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Millennium Management fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Millennium Management's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Millennium Management opened 1,144 new positions and closed 1,065 in Q2 2022.
- Millennium Management's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.